1
|
Guo J, Lv W, Wang Z, Shang Y, Yang F, Zhang X, Xiao K, Zhang S, Pan X, Han Y, Zong L, Hu W. Prognostic Value of Inflammatory and Nutritional Markers for Patients With Early-Stage Poorly-to Moderately-Differentiated Cervical Squamous Cell Carcinoma. Cancer Control 2023; 30:10732748221148913. [PMID: 36599103 PMCID: PMC9982384 DOI: 10.1177/10732748221148913] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023] Open
Abstract
BACKGROUND The neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR), systemic immune-inflammatory index (SII), systemic inflammation response index (SIRI), and Onodera's prognostic nutritional index (OPNI) have been reported as prognostic markers for various cancers. We evaluated the prognostic value of the NLR, PLR, MLR, SII, SIRI, and OPNI for poorly-to moderately-differentiated cervical squamous cell carcinoma (CSCC). PATIENTS AND METHODS We retrospectively analyzed the cases of 109 patients with early-stage poorly-to moderately-differentiated CSCC who underwent radical surgery at our institution in 2014-2017. The optimal cutoff points for the NLR, PLR, MLR, SII, SIRI, and OPNI were determined by receiver operating characteristic curves. Overall survival was analyzed by the Kaplan-Meier method. We performed a multivariate analysis using the Cox proportional hazard regression model to determine the independent prognostic indicators for early-stage poorly-to moderately-differentiated CSCC. RESULTS The appropriate cutoff points were: NLR, 1.72; PLR, 111.96; MLR, .24; SII, 566.23; SIRI, 1.38; and OPNI, 52.68. The OS of the patients with a high OPNI (P = .04), low SII (P = .03), or low SIRI (P = .01) was significantly better. The uni- and multivariate analyses identified only the OPNI as an independent prognostic marker for early-stage poorly-to moderately-differentiated CSCC (P = .04 and P = .02). CONCLUSION The OPNI is an independent prognostic marker for early-stage poorly-to moderately-differentiated CSCC; the NLR, PLR, MLR, SII, and SIRI are not.
Collapse
Affiliation(s)
- Jianfei Guo
- Graduate School of Medicine, Changzhi Medical
College, Changzhi, PR China
| | - Weiqing Lv
- Department of Gynecology, Yuncheng Central
Hospital, The Affiliated Hospital of Shanxi Medical University,
Shanxi, PR China
| | - Zehua Wang
- Department of Anesthesiology, Heji Hospital Affiliated to Changzhi
Medical College, Changzhi, PR China
| | - Yun Shang
- Department of Gynecology, Yuncheng Central
Hospital, The Affiliated Hospital of Shanxi Medical University,
Shanxi, PR China
| | - Fan Yang
- Department of Central Laboratory,
Changzhi People’s Hospital, The Affiliated Hospital of Shanxi
Medical University, Changzhi, PR China
| | - Xiaomin Zhang
- Department of Central Laboratory,
Changzhi People’s Hospital, The Affiliated Hospital of Shanxi
Medical University, Changzhi, PR China
| | - Keyuan Xiao
- Department of Central Laboratory,
Changzhi People’s Hospital, The Affiliated Hospital of Shanxi
Medical University, Changzhi, PR China
| | - Shangyunduo Zhang
- Graduate School of Medicine, Changzhi Medical
College, Changzhi, PR China
| | - Xiaoqi Pan
- Graduate School of Medicine, Changzhi Medical
College, Changzhi, PR China
| | - Yan Han
- Department of Gynecology, Changzhi
People’s Hospital, The Affiliated Hospital of Shanxi
Medical University, Changzhi, PR China,Yan Han, PhD, Department of Gynecology,
Changzhi People’s Hospital, The Affiliated Hospital of Shanxi Medical
University, No. 502 Changxing Middle Road, Changzhi, Shanxi Province 1046000, PR
China.
| | - Liang Zong
- Department of Gastrointestinal
Surgery, Changzhi People’s Hospital, The Affiliated Hospital of Shanxi
Medical University, Changzhi, PR China,Liang Zong, PhD, Department of
Gastrointestinal Surgery, Changzhi People’s Hospital, The Affiliated Hospital of
Shanxi Medical University, No. 502 Changxing Middle Road, Changzhi, Shanxi
Province 1046000, PR China.
| | - Wenqing Hu
- Department of Gastrointestinal
Surgery, Changzhi People’s Hospital, The Affiliated Hospital of Shanxi
Medical University, Changzhi, PR China,Wenqing Hu, PhD, Department of
Gastrointestinal Surgery, Changzhi People’s Hospital, The Affiliated Hospital of
Shanxi Medical University, No. 502 Changxing Middle Road, Changzhi, Shanxi
Province 1046000, PR China.
| |
Collapse
|